These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4303692)

  • 21. [Activity of Italian trivalent OAC I-70 vaccine in relation to 3 foot-and-mouth disease viruses, Argentine O1, A24, A26, C3 viruses and Uruguayan O1, A24, C2 viruses].
    Bellani L; Nardelli L
    Bull Off Int Epizoot; 1972; 77(3):653-72. PubMed ID: 4659820
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of vaccination against foot-and-mouth disease on results of the immunodiffusion test for the demonstration of precipitating bovine leukosis virus antibodies].
    Straub OC
    Dtsch Tierarztl Wochenschr; 1983 Apr; 90(4):135-7. PubMed ID: 6305624
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunology of foot-and-mouth disease in swine: experimental inactivated-virus vaccines.
    Bachrach HL; McKercher PD
    J Am Vet Med Assoc; 1972 Feb; 160(4):521-6. PubMed ID: 4337840
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of new adjuvants in an emergency vaccine against foot-and-mouth disease virus: evaluation of conferred immunity.
    Quattrocchi V; Bianco V; Fondevila N; Pappalardo S; Sadir A; Zamorano P
    Dev Biol (Basel); 2004; 119():481-97. PubMed ID: 15742663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the immune response of foot-and-mouth disease vaccine type Asia-1 in pregnant ewes, lambs and evaluation of type O vaccine by challenge.
    Nair SP; Sen AK
    Acta Virol; 1994 Oct; 38(5):257-61. PubMed ID: 7725999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental inoculation of sheep with foot-and-mouth disease virus.
    Fernandez AA; Fernandes MV
    Bull Off Int Epizoot; 1970; 73(5):507-20. PubMed ID: 4337798
    [No Abstract]   [Full Text] [Related]  

  • 28. [An anti-foot-and-mouth disease vaccine from virus grown in a suspension of calf kidney cells].
    Likhachev NV; Zviagin IV; Makhniuk RA; Federova TL; Kazantseva NV; Molochnikov VA; San'kov SD; Zueva NIa
    Veterinariia; 1967 Jan; 44(1):24-5. PubMed ID: 5628675
    [No Abstract]   [Full Text] [Related]  

  • 29. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
    Fowler VL; Paton DJ; Rieder E; Barnett PV
    Vaccine; 2008 Apr; 26(16):1982-9. PubMed ID: 18342409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of guinea-pigs against foot-and-mouth disease by simultaneous inoculation of sendai virus and inactivated foot-and-mouth disease vaccine.
    Herniman KA; Sellers RF
    Arch Gesamte Virusforsch; 1972; 37(1):97-103. PubMed ID: 4336969
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of the Ai variant of deproteinized foot-and-mouth disease virus in the production of vaccine].
    Klimov NM; Malakhov AG
    Veterinariia; 1968 Jan; 45(1):26-8. PubMed ID: 4312578
    [No Abstract]   [Full Text] [Related]  

  • 32. The eradication of foot-and-mouth disease in Thailand.
    Wongsongsarn C; Bhuchongsmutta C; Dissamarn R
    Bull Off Int Epizoot; 1968; 69(1):85-8. PubMed ID: 4301804
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaccination against foot-and-mouth disease.
    Morgan DO; Moore DM; McKercher PD
    Prog Clin Biol Res; 1980; 47():169-78. PubMed ID: 6259663
    [No Abstract]   [Full Text] [Related]  

  • 34. Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by a combination of binary ethyleneimine and formaldehyde.
    Barteling SJ; Cassim NI
    Dev Biol (Basel); 2004; 119():449-55. PubMed ID: 15742659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The inactivation of foot-and-mouth disease virus by ethylethyleneimine and the use of the inactivated virus in the preparation of vaccines].
    Bauer K
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):285-97. PubMed ID: 4318509
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies of the action of a new anti-aphthous vaccine in swine].
    Giraud M; Guilloteau B; Perrot A; Debrock C; Prunet P
    Bull Off Int Epizoot; 1969; 71(3-4):285-306. PubMed ID: 4323522
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of chemical agents on foot-and-mouth disease virus production in cell cultures.
    Polatnick J
    Am J Vet Res; 1965 Sep; 26(114):1051-5. PubMed ID: 4287298
    [No Abstract]   [Full Text] [Related]  

  • 39. Further information on the survival of modified foot-and-mouth disease virus in cattle.
    Augé de Mello P; Honigman MN; Fernandes MV; Gomes I
    Bull Off Int Epizoot; 1970; 73(5):489-505. PubMed ID: 4337797
    [No Abstract]   [Full Text] [Related]  

  • 40. Early response of cattle and swine to inactivated foot-and-mouth disease vaccine.
    Graves JH; McKercher PD; Farris HE; Cowan KM
    Res Vet Sci; 1968 Jan; 9(1):35-40. PubMed ID: 5689040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.